350 related articles for article (PubMed ID: 33077873)
21. Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia.
De Biasi S; Lo Tartaro D; Meschiari M; Gibellini L; Bellinazzi C; Borella R; Fidanza L; Mattioli M; Paolini A; Gozzi L; Jaacoub D; Faltoni M; Volpi S; Milić J; Sita M; Sarti M; Pucillo C; Girardis M; Guaraldi G; Mussini C; Cossarizza A
Eur J Immunol; 2020 Sep; 50(9):1283-1294. PubMed ID: 32910469
[TBL] [Abstract][Full Text] [Related]
22. Clinical Characteristics and Factors Associated With Long-Term Viral Excretion in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Single-Center 28-Day Study.
Shi D; Wu W; Wang Q; Xu K; Xie J; Wu J; Lv L; Sheng J; Guo J; Wang K; Fang D; Li Y; Li L
J Infect Dis; 2020 Aug; 222(6):910-918. PubMed ID: 32614392
[TBL] [Abstract][Full Text] [Related]
23. Assessing SARS-CoV-2 RNA levels and lymphocyte/T cell counts in COVID-19 patients revealed initial immune status as a major determinant of disease severity.
Han M; Xu M; Zhang Y; Liu Z; Li S; He T; Li J; Gao Y; Liu W; Li T; Chen Z; Huang X; Cheng G; Wang J; Dittmer U; Witzke O; Zou G; Li X; Lu M; Zhang Z
Med Microbiol Immunol; 2020 Dec; 209(6):657-668. PubMed ID: 32860073
[TBL] [Abstract][Full Text] [Related]
24. The Science Underlying COVID-19: Implications for the Cardiovascular System.
Liu PP; Blet A; Smyth D; Li H
Circulation; 2020 Jul; 142(1):68-78. PubMed ID: 32293910
[TBL] [Abstract][Full Text] [Related]
25. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
Front Immunol; 2020; 11():581338. PubMed ID: 33123167
[TBL] [Abstract][Full Text] [Related]
26. Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China.
Tan M; Liu Y; Zhou R; Deng X; Li F; Liang K; Shi Y
Immunology; 2020 Jul; 160(3):261-268. PubMed ID: 32460357
[TBL] [Abstract][Full Text] [Related]
27. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent.
Mazzoni A; Salvati L; Maggi L; Capone M; Vanni A; Spinicci M; Mencarini J; Caporale R; Peruzzi B; Antonelli A; Trotta M; Zammarchi L; Ciani L; Gori L; Lazzeri C; Matucci A; Vultaggio A; Rossi O; Almerigogna F; Parronchi P; Fontanari P; Lavorini F; Peris A; Rossolini GM; Bartoloni A; Romagnani S; Liotta F; Annunziato F; Cosmi L
J Clin Invest; 2020 Sep; 130(9):4694-4703. PubMed ID: 32463803
[TBL] [Abstract][Full Text] [Related]
28. Inflammatory Cell Infiltration of Adrenals in COVID-19.
Zinserling VA; Semenova NY; Markov AG; Rybalchenko OV; Wang J; Rodionov RN; Bornstein SR
Horm Metab Res; 2020 Sep; 52(9):639-641. PubMed ID: 32629518
[TBL] [Abstract][Full Text] [Related]
29. Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease has not received enough attention till date.
Hanley B; Roufosse CA; Osborn M; Naresh KN
Br J Haematol; 2020 Jun; 189(6):1062-1063. PubMed ID: 32369628
[No Abstract] [Full Text] [Related]
30. The clinical course and its correlated immune status in COVID-19 pneumonia.
He R; Lu Z; Zhang L; Fan T; Xiong R; Shen X; Feng H; Meng H; Lin W; Jiang W; Geng Q
J Clin Virol; 2020 Jun; 127():104361. PubMed ID: 32344320
[TBL] [Abstract][Full Text] [Related]
31. [Pathological changes of the spleen in ten patients with coronavirus disease 2019(COVID-19) by postmortem needle autopsy].
Xu X; Chang XN; Pan HX; Su H; Huang B; Yang M; Luo DJ; Weng MX; Ma L; Nie X
Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):576-582. PubMed ID: 32340089
[No Abstract] [Full Text] [Related]
32. Clinical and immunological features of severe and moderate coronavirus disease 2019.
Chen G; Wu D; Guo W; Cao Y; Huang D; Wang H; Wang T; Zhang X; Chen H; Yu H; Zhang X; Zhang M; Wu S; Song J; Chen T; Han M; Li S; Luo X; Zhao J; Ning Q
J Clin Invest; 2020 May; 130(5):2620-2629. PubMed ID: 32217835
[TBL] [Abstract][Full Text] [Related]
33. Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications.
Allegra A; Di Gioacchino M; Tonacci A; Musolino C; Gangemi S
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32640747
[TBL] [Abstract][Full Text] [Related]
34. Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients.
Haghjooy Javanmard S; Vaseghi G; Manteghinejad A; Nasirian M
J Glob Antimicrob Resist; 2020 Sep; 22():862-863. PubMed ID: 32810639
[TBL] [Abstract][Full Text] [Related]
35. The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients.
Chen Y; Chen L; Deng Q; Zhang G; Wu K; Ni L; Yang Y; Liu B; Wang W; Wei C; Yang J; Ye G; Cheng Z
J Med Virol; 2020 Jul; 92(7):833-840. PubMed ID: 32243607
[TBL] [Abstract][Full Text] [Related]
36. Clinical Performance of SARS-CoV-2 Molecular Tests.
Green DA; Zucker J; Westblade LF; Whittier S; Rennert H; Velu P; Craney A; Cushing M; Liu D; Sobieszczyk ME; Boehme AK; Sepulveda JL
J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32513858
[TBL] [Abstract][Full Text] [Related]
37. Detection and quantification of SARS-CoV-2 by droplet digital PCR in real-time PCR negative nasopharyngeal swabs from suspected COVID-19 patients.
Alteri C; Cento V; Antonello M; Colagrossi L; Merli M; Ughi N; Renica S; Matarazzo E; Di Ruscio F; Tartaglione L; Colombo J; Grimaldi C; Carta S; Nava A; Costabile V; Baiguera C; Campisi D; Fanti D; Vismara C; Fumagalli R; Scaglione F; Epis OM; Puoti M; Perno CF
PLoS One; 2020; 15(9):e0236311. PubMed ID: 32898153
[TBL] [Abstract][Full Text] [Related]
38. Longitudinal Analysis of T and B Cell Receptor Repertoire Transcripts Reveal Dynamic Immune Response in COVID-19 Patients.
Niu X; Li S; Li P; Pan W; Wang Q; Feng Y; Mo X; Yan Q; Ye X; Luo J; Qu L; Weber D; Byrne-Steele ML; Wang Z; Yu F; Li F; Myers RM; Lotze MT; Zhong N; Han J; Chen L
Front Immunol; 2020; 11():582010. PubMed ID: 33117392
[TBL] [Abstract][Full Text] [Related]
39. Lymphocyte subsets with the lowest decline at baseline and the slow lowest rise during recovery in COVID-19 critical illness patients with diabetes mellitus.
Liu D; Lan L; Luo D; Zhao B; Wei G; He Y; Zhang R; Liu Y
Diabetes Res Clin Pract; 2020 Sep; 167():108341. PubMed ID: 32707212
[TBL] [Abstract][Full Text] [Related]
40. Reappearance of effector T cells is associated with recovery from COVID-19.
Odak I; Barros-Martins J; Bošnjak B; Stahl K; David S; Wiesner O; Busch M; Hoeper MM; Pink I; Welte T; Cornberg M; Stoll M; Goudeva L; Blasczyk R; Ganser A; Prinz I; Förster R; Koenecke C; Schultze-Florey CR
EBioMedicine; 2020 Jul; 57():102885. PubMed ID: 32650275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
